Company / Depreciation & Amortization
TENAX THERAPEUTICS, INC. Depreciation & Amortization History
FY2012-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$8.0K
FY2024
5-year range
$8.0K / $150.5K
FY2020-FY2024
Trend
-94.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $150,489 to $8,000 over the past 9 years.
Based on SEC 10-K filings.
$8,000 in FY2024 with a 10-year CAGR of -25.3%.
Improved from $150,489 to $8,000 over the past 9 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -25.3%
Key checks
Key Insights
- In FY2024, depreciation & amortization decreased 94.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $8.0K | -94.7% |
| FY2016 | $150.5K | +0.0% |
| FY2015 | $150.5K | +1.1% |
| FY2014 | $148.8K | -28.0% |
| FY2013 | $206.7K | -33.5% |
| FY2012 | $311.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026